Rilpivirine resistance associated mutations in HIV-1 infected pregnant women

Enferm Infecc Microbiol Clin. 2015 Aug-Sep;33(7):498-9. doi: 10.1016/j.eimc.2014.12.005. Epub 2015 Jan 29.

Authors

Diego M Cecchini¹, Inés Zapiola², Claudia G Rodriguez³, María B Bouzas²

Affiliations

¹ Hospital Cosme Argerich, Infectious Diseases Unit, Buenos Aires, Argentina. Electronic address: [email protected].
² Hospital Francisco J. Muñiz, Virology Unit, Buenos Aires, Argentina.
³ Hospital Cosme Argerich, Infectious Diseases Unit, Buenos Aires, Argentina.

PMID: 25639908
DOI: 10.1016/j.eimc.2014.12.005

No abstract available

Publication types

Letter

MeSH terms

Drug Resistance, Multiple, Viral / genetics
Drug Resistance, Viral / genetics*
Female
HIV Infections / drug therapy*
HIV Infections / virology
HIV-1 / drug effects*
HIV-1 / genetics
Humans
Point Mutation*
Pregnancy
Pregnancy Complications, Infectious / drug therapy*
Pregnancy Complications, Infectious / virology
Reverse Transcriptase Inhibitors / pharmacology*
Reverse Transcriptase Inhibitors / therapeutic use
Rilpivirine / pharmacology*
Rilpivirine / therapeutic use

Substances

Reverse Transcriptase Inhibitors
Rilpivirine